Altera's $2 billion IPO forces fresh Intel valuation

Altera, the programmable‑chip maker that Intel sold control of last year, has confidentially filed for a U.S. IPO. The filing, announced on September 15, could raise more than $2 billion, according to Reuters. Silver Lake holds a 51% stake after investing $4.46 billion for control, while Intel retains 49% of the company. The move would create a new public valuation for Intel’s remaining interest in Altera, giving the chip giant a clearer picture of the worth of its programmable‑silicon assets.

The timing of the IPO comes as artificial‑intelligence workloads drive demand for field‑programmable gate arrays (FPGAs). Intel’s own foray into AI‑accelerated data centres has been uneven, and its recent acquisition of Xilinx by AMD in 2022 shows how rivals are bundling FPGAs with CPUs and GPUs to offer heterogeneous solutions. Xilinx’s portfolio of FPGAs, adaptive system‑on‑chips and software can sit alongside AMD’s EPYC CPUs and Instinct accelerators, creating a compelling product mix for large‑scale AI and high‑performance computing customers. Altera’s chips serve industrial, communications, aerospace and data‑center markets, and management projects mid‑20% revenue growth by 2026, though investors will need to assess how much of that is AI‑driven.

For Intel, an Altera IPO could unlock value that is currently buried inside the larger company. The semiconductor maker is under pressure to raise capital for a foundry expansion and to regain competitiveness in mainstream CPUs and advanced manufacturing. By bringing Altera’s valuation into the public eye, Intel would have a clearer benchmark for its remaining stake and could use the proceeds to shore up its balance sheet. Hedge fund activity shows a growing interest in Intel and AMD, with 138 funds holding Intel shares in Q2, up from 112 in Q1, while AMD ownership rose to 164 funds from 134. The IPO could also shift investor focus from Intel’s broader turnaround to the more specific growth prospects of programmable silicon.

However, the market may over‑price any AI label. Altera’s offering terms are still unannounced, so the $2 billion figure remains a possibility rather than a firm target. Investors will weigh the company’s projected growth against the broader AI chip landscape and the risk that not all FPGA workloads will migrate into AMD’s ecosystem. The IPO could also alter short‑selling dynamics, as Intel had about 152.2 million shares sold short as of August 31, roughly 3% of the public float. In short, the Altera IPO could provide Intel with a fresh valuation and a new capital source, but it will also expose the company’s programmable‑chip business to the same volatility that has marked AI‑related investments in recent months.